Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel Shareholders OK Gen-Probe Takeover

NEW YORK (GenomeWeb News) – Shareholders of Tepnel Life Sciences have approved the acquisition of the firm by Gen-Probe.

Gen-Probe said today that more than 99 percent of Tepnel shareholders voted in favor of the deal, which was announced in late January. Under terms of the transaction, Gen-Probe will pay 27.1 pence ($.386) per share in cash for each share of Tepnel outstanding — valuing the deal at $132.2 million.

The boards of directors of both firms have already unanimously approved the deal, which Gen-Probe said it expects to close on or around April 8.

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.